Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000392801

Medchemexpress LLC Colchicine | 64-86-8 | 99.93% | 399.44 | 25 MG
SDP

Catalog No. 5000392801
Encompass_Preferred

Colchicine (Standard) is the analytical standard for Colchicine, an orally active alkaloid. It acts as a potent tubulin inhibitor and a microtubule disrupting agent, inhibiting microtubule polymerization with an IC50 of 3 nM. It also functions as a competitive antagonist of α3 glycine receptors (GlyRs) and can prevent NSAID-induced small intestinal injury. Colchicine demonstrates extensive anti-inflammatory, immunosuppressive, and anti-fibrosis effects, suggesting its potential for gouty arthritis research.

  • Analytical standard for research and analytical applications.
  • Potent tubulin inhibitor and microtubule disrupting agent.
  • Inhibits microtubule polymerization with an IC50 of 3 nM.
  • Competitive antagonist of the α3 glycine receptors (GlyRs).
  • Prevents NSAID-induced small intestinal injury.
  • Extensive anti-inflammatory, immunosuppressive, and anti-fibrosis effects.
  • Potential for gouty arthritis research.

Catalog No. 50-003-92801 Supplier Medchemexpress LLC Supplier No. 25MGHY16569R
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Colchicine (Standard) is the analytical standard for Colchicine, an orally active alkaloid. It acts as a potent tubulin inhibitor and a microtubule disrupting agent, inhibiting microtubule polymerization with an IC50 of 3 nM. It also functions as a competitive antagonist of α3 glycine receptors (GlyRs) and can prevent NSAID-induced small intestinal injury. Colchicine demonstrates extensive anti-inflammatory, immunosuppressive, and anti-fibrosis effects, suggesting its potential for gouty arthritis research.

  • Analytical standard for research and analytical applications.
  • Potent tubulin inhibitor and microtubule disrupting agent.
  • Inhibits microtubule polymerization with an IC50 of 3 nM.
  • Competitive antagonist of the α3 glycine receptors (GlyRs).
  • Prevents NSAID-induced small intestinal injury.
  • Extensive anti-inflammatory, immunosuppressive, and anti-fibrosis effects.
  • Potential for gouty arthritis research.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.